{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:38:45Z","timestamp":1761154725516,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ijrobp.2004.05.017","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T07:22:24Z","timestamp":1104391344000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Monoclonal antibody to HER-2\/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2\/neu oncoprotein"],"prefix":"10.1016","volume":"61","author":[{"given":"Shinsuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Iwanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sonoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Tsurumaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.05.017_BIB1","first-page":"531","article-title":"Trimodality treatment versus surgery alone for esophageal cancer","volume":"43","author":"Jiao","year":"2002","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/028418602753669472","article-title":"Chemoradiotherapy of esophageal cancer","volume":"41","author":"Albertsson","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000658-200209000-00014","article-title":"Treatment outcomes of resected esophageal cancer","volume":"236","author":"Hofstetter","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0003-4975(02)04401-6","article-title":"Value of radiotherapy after radical surgery for esophageal carcinoma","volume":"75","author":"Xiao","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1442-2050.2003.00280.x","article-title":"Preoperative chemoradiotherapy in cancer of the thoracic esophagus","volume":"16","author":"Terrosu","year":"2003","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1055-3207(18)30212-6","article-title":"Making sense of multimodality therapy for esophageal cancer","volume":"8","author":"Krasna","year":"1999","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/hupa.2002.30183","article-title":"Prognostic value of immunohistochemical expressions of p53, HER-2\/neu, and bcl-2 in Stage I non-small-cell lung cancer","volume":"33","author":"Han","year":"2002","journal-title":"Human Pathol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.bjc.6600286","article-title":"Evaluation of HER-2\/neu gene amplification and protein expression in non-small cell lung carcinomas","volume":"86","author":"Hirsch","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB11","first-page":"761","article-title":"Amplification of the c-erbB-2 (HER-2\/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization","volume":"151","author":"Ishikawa","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB12","first-page":"4164","article-title":"Combination of EGFR, HER-2\/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members","volume":"5","author":"Xia","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0","article-title":"Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus","volume":"73","author":"Nakamura","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jcp.47.1.23","article-title":"Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma","volume":"47","author":"Flejou","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0748-7983(97)80139-4","article-title":"Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma","volume":"23","author":"Hardwick","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/gut.33.8.1033","article-title":"Oncogenes and onco-supressor gene in adenocarcinoma of the oesophagus","volume":"33","author":"Jankowski","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(93)90205-N","article-title":"HER-2\/neu","volume":"75","author":"Sauter","year":"1993","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB18","first-page":"28","article-title":"Coexpression of Grb7 with epidermal growth factor receptor or Her2\/erbB2 in human advanced esophageal carcinoma","volume":"57","author":"Tanaka","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0748-7983(98)92403-9","article-title":"C-erbB-2 protein in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions","volume":"24","author":"Lam","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0748-7983(97)80139-4","article-title":"Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma","volume":"23","author":"Hardwick","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB21","first-page":"2797","article-title":"Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas","volume":"15","author":"Sou","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0360-3016(03)00782-X","article-title":"C-erbB-2 oncoprotein expression is related to chemoradioresistance in esophageal squamous cell carcinoma","volume":"57","author":"Akamatsu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB23","first-page":"953","article-title":"Expression of the HER-2\/neu proto-oncogene in normal human adult and fetal tissues","volume":"5","author":"Press","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1349-7006.1989.tb01654.x","article-title":"Association of elevated expression of the c-erbB-2 protein with spread of breast cancer","volume":"80","author":"Yamada","year":"1989","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2559.1989.tb01587.x","article-title":"The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues","volume":"15","author":"De Potter","year":"1989","journal-title":"Histopathology"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1988.239","article-title":"C-erbB-2 expression in benign and malignant breast disease","volume":"58","author":"Gusterson","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB27","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s004320050248","article-title":"Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy","volume":"125","author":"Nishioka","year":"1999","journal-title":"J Cancer Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF01215923","article-title":"Molecular and cellular feature of esophageal cancer cells","volume":"119","author":"Nishihira","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L","article-title":"Characterization of cell lines established from human gastric-esophageal adenocarcinomas","volume":"72","author":"Altorki","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB31","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.1999.17.7.1983","article-title":"Specificity of Hercep test in determining HER-2\/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system","volume":"17","author":"Jacobs","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ijc.1493","article-title":"Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma","volume":"94","author":"Uno","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB34","first-page":"1347","article-title":"Monoclonal antibody to HER-2\/neu receptor modulates repair of radiation induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene","volume":"59","author":"Pietras","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.onc.1201275","article-title":"Radiation-induced proliferation of the human A431 squamous carcinoma cells is independent on EGFR tyrosine phosphorylation","volume":"15","author":"Schmidt-Ullrich","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB36","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1091\/mbc.10.8.2493","article-title":"Radiation-induced release of transforming growth factor \u03b1 activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death","volume":"10","author":"Dent","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB37","first-page":"2884","article-title":"Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas","volume":"5","author":"Akimoto","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB38","first-page":"1935","article-title":"Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitiveity in squamous cell carcinomas of the head and neck","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/cncr.10372","article-title":"Monoclonal antibodies to target epidermal growth factor-positive tumors","volume":"94","author":"Herbst","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB40","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1038\/sj.onc.1204082","article-title":"The EGF receptor family as targets for cancer therapy","volume":"19","author":"Mendelsohn","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0360-3016(00)01560-1","article-title":"Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro","volume":"50","author":"Akimoto","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB42","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1038\/sj.onc.1201802","article-title":"Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells","volume":"16","author":"Carter","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB43","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1038\/sj.onc.1205500","article-title":"Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells","volume":"21","author":"Contessa","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2004.05.017_BIB44","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/sj.onc.1201029","article-title":"A subclass of tumor-inhibitory monoclonal antibodies to Erb-2\/HER2 blocks crosstalk with growth factor receptors","volume":"14","author":"Klapper","year":"1997","journal-title":"Oncogene"},{"issue":"Suppl. 12","key":"10.1016\/j.ijrobp.2004.05.017_BIB45","first-page":"60","article-title":"Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)","volume":"26","author":"Sliwkowski","year":"1999","journal-title":"Semin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604008168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604008168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:40:02Z","timestamp":1759743602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604008168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0360301604008168"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.05.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibody to HER-2\/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2\/neu oncoprotein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}